BACKGROUND: Cardiac resynchronization therapy (CRT) has recently emerged as a new modality for the treatment of patients with advanced heart failure (HF). HYPOTHESIS: Cardiac resynchronization therapy reduces atrial and ventricular arrhythmia burdens. METHODS: We analyzed the clinical data of patients who underwent an upgrade from a dual-chamber to a biventricular implantable cardioverter-defibrillator (ICD) at a tertiary care center. RESULTS: Nineteen patients (age 67 +/- 10 years, 18 men, left ventricular [LV] ejection fraction 0.24 +/- 0.07) underwent an upgrade to CRT-ICD. The LV lead was placed in a lateral position in 11, posterolateral in 4, and anterolateral in 3 patients. Baseline New York Heart Association class of HF improved in 11 (58%) patients who were considered "responders." After adjusting for the duration of follow-up before and after the upgrade, the number of patients receiving any ICD therapy decreased significantly from 13 to 4 (p = 0.004) and the total number of therapies decreased from 72 to 17 (p = 0.067). Also, the number of detections of sustained ventricular arrhythmias decreased from 40 to 11 episodes (p = 0.05), but the decrease in the number of detected supraventricular arrhythmias and mode switch episodes was not significant. The reduction in the ventricular arrhythmia load was independent of whether or not the patient responded to CRT. CONCLUSION: Our data suggest that CRT reduces ventricular but not atrial arrhythmia burden in patients with HF irrespective of their clinical response. This suggests that the reduction in arrhythmia is primarily an electrical phenomenon. Further studies are needed to confirm these findings and to uncover their underlying mechanisms.
BACKGROUND: Cardiac resynchronization therapy (CRT) has recently emerged as a new modality for the treatment of patients with advanced heart failure (HF). HYPOTHESIS: Cardiac resynchronization therapy reduces atrial and ventricular arrhythmia burdens. METHODS: We analyzed the clinical data of patients who underwent an upgrade from a dual-chamber to a biventricular implantable cardioverter-defibrillator (ICD) at a tertiary care center. RESULTS: Nineteen patients (age 67 +/- 10 years, 18 men, left ventricular [LV] ejection fraction 0.24 +/- 0.07) underwent an upgrade to CRT-ICD. The LV lead was placed in a lateral position in 11, posterolateral in 4, and anterolateral in 3 patients. Baseline New York Heart Association class of HF improved in 11 (58%) patients who were considered "responders." After adjusting for the duration of follow-up before and after the upgrade, the number of patients receiving any ICD therapy decreased significantly from 13 to 4 (p = 0.004) and the total number of therapies decreased from 72 to 17 (p = 0.067). Also, the number of detections of sustained ventricular arrhythmias decreased from 40 to 11 episodes (p = 0.05), but the decrease in the number of detected supraventricular arrhythmias and mode switch episodes was not significant. The reduction in the ventricular arrhythmia load was independent of whether or not the patient responded to CRT. CONCLUSION: Our data suggest that CRT reduces ventricular but not atrial arrhythmia burden in patients with HF irrespective of their clinical response. This suggests that the reduction in arrhythmia is primarily an electrical phenomenon. Further studies are needed to confirm these findings and to uncover their underlying mechanisms.
Authors: C P Lau; C M Yu; E Chau; K Fan; H F Tse; K Lee; M O Tang; S H Wan; T C Law; P Y Lee; Y M Lam; M R Hill Journal: Pacing Clin Electrophysiol Date: 2000-11 Impact factor: 1.976
Authors: William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Anil-Martin Sinha; Karsten Filzmaier; Ole-Alexander Breithardt; Dagmar Kunz; Jürgen Graf; Kai U Markus; Peter Hanrath; Christoph Stellbrink Journal: Am J Cardiol Date: 2003-03-15 Impact factor: 2.778
Authors: Philip B Adamson; Karen J Kleckner; Warren L VanHout; Sriram Srinivasan; William T Abraham Journal: Circulation Date: 2003-07-14 Impact factor: 29.690
Authors: Michael R Bristow; Leslie A Saxon; John Boehmer; Steven Krueger; David A Kass; Teresa De Marco; Peter Carson; Lorenzo DiCarlo; David DeMets; Bill G White; Dale W DeVries; Arthur M Feldman Journal: N Engl J Med Date: 2004-05-20 Impact factor: 91.245
Authors: James B Young; William T Abraham; Andrew L Smith; Angel R Leon; Randy Lieberman; Bruce Wilkoff; Robert C Canby; John S Schroeder; L Bing Liem; Shelley Hall; Kevin Wheelan Journal: JAMA Date: 2003-05-28 Impact factor: 56.272
Authors: A B Gopalamurugan; G Ganesha Babu; Dominic P Rogers; Adam L Simpson; Syed Y Ahsan; Pier D Lambiase; Anthony W Chow; Martin D Lowe; Edward Rowland; Oliver R Segal Journal: Front Physiol Date: 2014-09-17 Impact factor: 4.566